Hemodialysis vascular access is often termed the “lifeline” of patients with end-stage renal disease. However, due to frequent complications, it is also considered the “Achilles heel” of hemodialysis therapy. While traditional patient safety efforts have focused on clinician training and patient education, this chapter advocates for a transformative approach—one that prioritizes individualization of care and active...
In the realm of patient safety, the spotlight often shines on pharmacovigilance—the science of monitoring drug side effects. However, a parallel and equally critical discipline operates in the shadows: Medical Device Vigilance.
Adverse Childhood Experiences (ACEs) are potentially traumatic events occurring before the age of 18. These experiences range from direct personal harm to environmental instability. The term originates from a landmark study by the CDC and Kaiser Permanente (1995-1997) which established a strong, graded relationship between ACEs and negative health outcomes in adulthood.
Lock therapy (also called catheter lock therapy or antibiotic lock therapy - ALT) refers to a technique where a high-concentration antimicrobial or anticoagulant solution is instilled into the lumen of an indwelling vascular access device (like a central venous catheter, port, or cannula) and allowing it to dwell for a specified period when the catheter is not in active use.
This is a critical and profound topic. Let's illustrate the difference between equality and equity in patient safety with detailed, healthcare-specific examples.
What Does "Back to Natural, Be Sustainable" Really Mean? This is a profound and complex topic that sits at the intersection of public desire, environmental science, and rigorous medical practice. Let's break it down in detail within the requested framework.
The traditional pharmacovigilance paradigm is centered on detecting adverse drug reactions (ADRs)—harmful and unintended responses to a drug used at normal doses. AMR, however, represents a reduction in a drug's intended clinical benefit. This fundamental shift—from monitoring safety to monitoring efficacy failure due to resistance—requires a significant evolution in PV practices.
Advancing Medication Safety Through Knowledge and Vigilance
